News
The inquiry involves a $5.8 million overpayment that Cherfilus-McCormick's healthcare company mistakenly received during the COVID-19 pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback